Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLOT Combined With Toripalimab in Advanced Gastric Cancer With Peritoneal Metastasis
NCT04886193Unknown
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Apr 2021
- Primary completion
- May 2022
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of toripalimab in gastric cancer (GC), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoints: Surgical conversion rate and Tumor Regression Grade. Status: unknown.
02
Drugs
toripalimab
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT04886193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04886193.